Log in to save to my catalogue

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional se...

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional se...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1413963

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR : a meta-analysis

About this item

Full title

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR : a meta-analysis

Publisher

Ottawa, ON: Canadian Medical Association

Journal title

Journal of psychiatry & neuroscience, 2006-03, Vol.31 (2), p.122-131

Language

English

Formats

Publication information

Publisher

Ottawa, ON: Canadian Medical Association

More information

Scope and Contents

Contents

Escitalopram is the most selective of the selective serotonin reuptake inhibitor (SSRI) antidepressants. Previous studies have suggested that escitalopram is superior to citalopram in efficacy. We conducted a meta-analysis of studies in which escitalopram was compared with other antidepressants to assess the relative efficacy of these agents.
Da...

Alternative Titles

Full title

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR : a meta-analysis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1413963

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1413963

Other Identifiers

ISSN

1180-4882

E-ISSN

1488-2434

How to access this item